Creon contains a mixture of enzyme constituents that are needed to enable proper food digestion and its minimicrosphere technology allows for optimal delivery of these enzymes. As a result, Creon is the most prescribed pancreatic enzyme in the world.

Solvay Pharmaceuticals acknowledged that the Creon identity was inconsistently implemented and was in need of harmonisation.

After conducting a brand workshop with the Creon Global Product Strategy team, Origin developed a variety of concepts that focused on typography, iconic usage and colour application while addressing the visual brand identity positioning.

The newly created identity capitalises on Solvay’s expertise and patented minimicrosphere technology and reinforces it as the ideal choice for both clinicians and patients.

A colour coding system was also developed to differentiate the various dosages.